Could a simple inhaler shield your heart during stent surgery?
NCT ID NCT07397351
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an inhaled medicine called Aroxxen to see if it can reduce heart damage during and after a common procedure to open blocked heart arteries (stent placement). About 180 adults with coronary artery disease will receive either Aroxxen or standard care. Researchers will measure heart injury markers in the blood to find the best dose and duration of treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
City Multidisciplinary Hospital No. 2
RECRUITINGSaint Petersburg, Russia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Software-Guided heart procedures: a new standard for coronary care?
- Heart patients may stay active longer with coach calls and group support
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program
- Can balloon timing make or break heart artery success?
- Can we predict which heart aneurysms will grow?
- Can a higher dose of adenosine sharpen heart scans?